PNC Financial Services Group’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4
Closed -$2K 4382
2017
Q4
$2K Hold
4
﹤0.01% 4061
2017
Q3
$3K Hold
4
﹤0.01% 3979
2017
Q2
$3K Buy
+4
New +$3.35K ﹤0.01% 3960
2016
Q4
Sell
-10
Closed -$8K 4182
2016
Q3
$8K Hold
10
﹤0.01% 3564
2016
Q2
$8K Sell
10
-2
-17% -$1.67K ﹤0.01% 3669
2016
Q1
$11K Buy
12
+2
+20% +$1.91K ﹤0.01% 3555
2015
Q4
$10K Hold
10
﹤0.01% 3620
2015
Q3
$9K Buy
+10
New +$10.4K ﹤0.01% 3738

Other funds holding AGN.PRA

PNC Financial Services Group's AGN.PRA Position: Q1 2018 in Review

PNC Financial Services Group sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 4 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in AGN.PRA in Q3 2015 and held it in 8 quarters. The position peaked at $11K in Q1 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • PNC Financial Services Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 4 Allergan plc shares in Q1 2018, an estimated $2K.
  • PNC Financial Services Group first reported a position in Allergan plc in Q3 2015 and held it in 8 quarters.
  • PNC Financial Services Group's Allergan plc position peaked at $11K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on PNC Financial Services Group's 13F filing for Q1 2018, filed 11 May 2018.